Modelling normal tissue toxicity in pancreatic chemoradiotherapy

Modelling normal tissue toxicity in pancreatic chemoradiotherapy

<p>The relationship between radiation dose and toxicity in pancreatic chemoradiotherapy is not well understood. Clinically, excessive normal tissue toxicity is avoided by placing a constraint on the volume of the organ receiving a dose above a threshold. Dose-volume constraints lack spatial...

ver descrição completa

Detalhes bibliográficos
Autor principal:	Witztum, A
Outros Autores:	Hawkins, M
Formato:	Thesis
Publicado em:	2018

Registos relacionados

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
Por: Holyoake, D, et al.
Publicado em: (2016)

Normal tissue complication probability model for severe radiation-induced lymphopenia in patients with pancreatic cancer treated with concurrent chemoradiotherapy
Por: Fuki Koizumi, et al.
Publicado em: (2025-01-01)

Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer
Por: Holyoake, DLP, et al.
Publicado em: (2018)

Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy
Por: Holyoake, D, et al.
Publicado em: (2017)

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
Por: V. Yu. Skoropad, et al.
Publicado em: (2018-07-01)

EP-1721: Feature extraction from duodenal dose surface maps to predict toxicity in pancreatic chemoradiation
Por: Witztum, A, et al.
Publicado em: (2016)

Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control
Por: Alexander Willner, et al.
Publicado em: (2023-12-01)

Acute chemoradiotherapy toxicity in cervical cancer patients
Por: Radojevic Marija Zivkovic, et al.
Publicado em: (2020-09-01)

Cardiac toxicity in children and adolescents with Hodgkin lymphoma after chemoradiotherapy
Por: R. I. Feoktistov, et al.
Publicado em: (2022-11-01)

Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
Por: Verbeke, C. S., et al.
Publicado em: (2006)

Establishment of Pancreatic Organoids from Normal Tissue and Tumors
Por: Else Driehuis, et al.
Publicado em: (2020-12-01)

Neoadjuvant chemoradiotherapy has a potential role in pancreatic carcinoma
Por: Geertjan van Tienhoven MD, PhD, et al.
Publicado em: (2011-01-01)

[Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis].
Por: Brunner, T
Publicado em: (2012)

Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question?
Por: Emilia Sawicka, et al.
Publicado em: (2016-06-01)

Long-term Survivor of Unresectable Pancreatic Cancer Treated with Concurrent Chemoradiotherapy
Por: Yun Je Song, et al.
Publicado em: (2024-01-01)

Inflammatory Parameters as Available Prognostic Factors for Pancreatic Cancer after Chemoradiotherapy
Por: Chang Min Cho
Publicado em: (2018-05-01)

Gastrointestinal Hemorrhage after Concurrent Chemoradiotherapy in Locally Advanced Pancreatic Cancer
Publicado em: (2013-01-01)

Sarcopenia Is Associated With Hematologic Toxicity During Chemoradiotherapy in Patients With Anal Carcinoma
Por: Daniel Martin, et al.
Publicado em: (2020-08-01)

ACUTE AND LATE TOXICITY WITH CHEMORADIOTHERAPY FOR OROPHARYNGEAL CANCER DEPENDING ON THE FRACTIONATION OPTION
Por: Parkhomenko L. B.
Publicado em: (2018-12-01)

Extracellular Vesicles for the Treatment of Radiation-Induced Normal Tissue Toxicity in the Lung
Por: Pierre Montay-Gruel, et al.
Publicado em: (2021-03-01)

Is neoadjuvant chemoradiotherapy for pancreatic cancer beneficial: A systematic review and meta-analysis
Por: Wenhao Luo, et al.
Publicado em: (2022-11-01)

Could Preoperative Chemoradiotherapy Lead to the Survival Benefit of Patients with Resectable Pancreatic Cancer?
Por: Yoon Suk Lee
Publicado em: (2020-04-01)

Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits
Por: O Wiklund, et al.
Publicado em: (1987-09-01)

Can protons reduce bone marrow toxicity in definitive chemoradiotherapy for oesophageal tumours?
Por: Warren, S, et al.
Publicado em: (2016)

Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women
Por: Weiping Wang, et al.
Publicado em: (2017-08-01)

A case of perforation of a pancreatic duct by a pancreatic stent during chemoradiotherapy for pancreatic head cancer: a case report
Por: Takuya Mori, et al.
Publicado em: (2019-01-01)

Radiomics approach for identifying radiation-induced normal tissue toxicity in the lung
Por: Olivia G. G. Drayson, et al.
Publicado em: (2024-10-01)

Spread-out Bragg peak FLASH: quantifying normal tissue toxicity in a murine model
Por: Line Kristensen, et al.
Publicado em: (2024-07-01)

Use of Intraoperative Radiotherapy in Pancreatic Cancer After Neoadjuvant Chemoradiotherapy: First National Application
Por: Emin KÖSE, et al.
Publicado em: (2016-12-01)

Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy
Por: Xiaofei Zhu, et al.
Publicado em: (2021-06-01)

Consolidative Chemoradiotherapy After Induced Chemotherapy Is an Optimal Regimen for Locally Advanced Pancreatic Cancer
Por: Lili Wu, et al.
Publicado em: (2020-01-01)

Normal tissue toxicity after small field hypofractionated stereotactic body radiation
Por: Constine Louis S, et al.
Publicado em: (2008-10-01)

Survival and toxicity outcomes of induction chemotherapy followed by concurrent chemoradiotherapy compared with concurrent chemoradiotherapy alone in inoperable stage III and IVA/B head and neck cancer
Por: Sajib Kumar Talukdhar, et al.
Publicado em: (2022-03-01)

Toxic Metal and Essential Element Concentrations in the Blood and Tissues of Pancreatic Ductal Adenocarcinoma Patients
Por: Giovanni Forte, et al.
Publicado em: (2024-01-01)

Characterizing cis-regulatory variation in the transcriptome of histologically normal and tumor-derived pancreatic tissues
Por: Zhang, M, et al.
Publicado em: (2017)

Radiosensitation in vivo by histone deacetylase inhibition with no increase in early normal tissue radiation toxicity
Por: Groselj, B, et al.
Publicado em: (2017)

Radiosensitisation in vivo by histone deacetylase inhibition with no increase in early normal tissue radiation toxicity
Por: Groselj, B, et al.
Publicado em: (2017)

268 DEGAS: Deep transfer learning reveals cancer-like transcriptional signatures in histologically normal prostate tissue and adjacent-normal tissues in pancreatic cancer
Por: Justin Couetil, et al.
Publicado em: (2023-04-01)

The outcome of a multidisciplinary approach incorporating neoadjuvant chemoradiotherapy with S1 for resectable pancreatic ductal adenocarcinoma
Por: Masaru Matsumura, et al.
Publicado em: (2023-03-01)

Impact of chemoradiotherapy on the survival of unresectable locally advanced pancreatic cancer: a retrospective cohort analysis
Por: Zi-Meng Wang, et al.
Publicado em: (2023-04-01)